Hyperion buying Andromeda; Zogenix sells Sumavel to Endo; Hydra/Boehringer collaborate; Medivation, OncoFusion partner; Theravance, Alimera raise debt; Sarepta, Agios sell stock; and Radius, Alder, Aldeyra set IPO terms.
written on 28.04.2014
Hyperion buying Andromeda; Zogenix sells Sumavel to Endo; Hydra/Boehringer collaborate; Medivation, OncoFusion partner; Theravance, Alimera raise debt; Sarepta, Agios sell stock; and Radius, Alder, Aldeyra set IPO terms.
See our Cookie Privacy Policy Here